6,962 results match your criteria Uric Acid Nephropathy

An evaluation of the roles of hematuria and uric acid in defining the prognosis of patients with IgA nephropathy.

Ron Hogg

Pediatr Nephrol 2021 May 13. Epub 2021 May 13.

, Kailua Kona, HI, USA.

In recent years, many significant advances have been made in determining which clinical manifestations and pathologic lesions can provide prognostic information for patients with IgA nephropathy (IgAN). However, some important questions remain, including the long-term consequences of hematuria, both macroscopic (MH) and microscopic (mH), in patients with IgAN. The importance of distinguishing patients who have a single episode of MH of long duration from those with recurrent episodes of short duration and the prognostic importance of the episodes of acute kidney injury (AKI) that sometimes accompany episodic MH will be discussed. Read More

View Article and Full-Text PDF

The association between variants in PLA2R and HLA-DQA1 and renal outcomes in patients with primary membranous nephropathy in Western China.

BMC Med Genomics 2021 May 8;14(1):123. Epub 2021 May 8.

Department of Nephrology and Institute of Nephrology, Sichuan Academy of Medical Science and Sichuan Provincial People's Hospital, Chengdu, 610072, China.

Background: Both Genome-wide associations and our previous study have shown that single nucleotide polymorphisms (SNPs) of M-type phospholipase A2 receptor (PLA2R) and human leukocyte antigen complex class II HLA-DQα-chain 1 (HLA-DQA1) gene were identified to be associated with primary membranous nephropathy (PMN). However, whether these SNPs affect clinical manifestation and renal outcome for PMN patients is poorly defined. Here, we evaluated whether there is an association between these SNPs and clinical manifestations and renal outcomes of PMN in a western Chinese cohort. Read More

View Article and Full-Text PDF

[Medical management of uric acid renal stones, case description.]

Arch Esp Urol 2021 May;74(4):442-445

Servicio de Urología. Hospital Universitario San Cecilio. Granada. España.

Uric acid renal stones are a frequent and important part of our clinical practice. Conservative treatment through diet and urine alkalinization with citrate and teobromina seem a promising combination for treatment of those stones. We show on our cases a complete resolution of staghorn stone at 12 weeks of allopurinol and lit-control pH Up treatment, without adverse events and avoiding surgical treatment. Read More

View Article and Full-Text PDF

Increased serum asprosin is correlated with diabetic nephropathy.

Diabetol Metab Syndr 2021 May 1;13(1):51. Epub 2021 May 1.

Department of Endocrinology, Qilu Hospital (Qingdao), Cheeloo College of Medicine, Shandong University, 758 Hefei Road, Shibei District, Qingdao, 266035, Shandong, China.

Objective: The adipokine asprosin, which was recently discovered, facilitates hepatic glucose production. The aim of this study is to see whether serum asprosin concentrations are linked to diabetic nephropathy (DN).

Methods: We performed this investigation in a group of 212 type 2 diabetes (T2DM) patients. Read More

View Article and Full-Text PDF

The Serum Uric Acid Level Is Related to the More Severe Renal Histopathology of Female IgA Nephropathy Patients.

J Clin Med 2021 Apr 27;10(9). Epub 2021 Apr 27.

Department of Internal Medicine, Daejeon St. Mary's Hospital, Catholic University of Korea, Daejeon 34943, Korea.

Hyperuricemia is a significant risk factor for cardiovascular morbidity and chronic kidney disease progression. IgA nephropathy (IgAN) is a well-known primary glomerular nephropathy. Hyperuricemia is associated with a poor prognosis in IgAN patients. Read More

View Article and Full-Text PDF

Pleiotropic Effects of Sodium-Glucose Cotransporter-2 Inhibitors: Renoprotective Mechanisms beyond Glycemic Control.

Int J Mol Sci 2021 Apr 22;22(9). Epub 2021 Apr 22.

Division of Gastroenterology and Nephrology, Faculty of Medicine, Tottori University, Yonago, Tottori 683-8504, Japan.

Diabetes mellitus is a major cause of chronic kidney disease and end-stage renal disease. However, the management of chronic kidney disease, particularly diabetes, requires vast improvements. Recently, sodium-glucose cotransporter-2 (SGLT2) inhibitors, originally developed for the treatment of diabetes, have been shown to protect against kidney injury via glycemic control, as well as various other mechanisms, including blood pressure and hemodynamic regulation, protection from lipotoxicity, and uric acid control. Read More

View Article and Full-Text PDF

Blood Lead Level and Renal Impairment among Adults: A Meta-Analysis.

Int J Environ Res Public Health 2021 Apr 15;18(8). Epub 2021 Apr 15.

Medical Technology, School of Allied Health Sciences, Walailak University, Tha Sala, Nakhon Si Thammarat 80160, Thailand.

The adult population in lead-related occupations or environmentally exposed to lead may be at risk for renal impairment and lead nephropathy. This meta-analysis aims to determine the impact of blood lead level (BLL) on renal function among middle-aged participants. Cross-sectional, longitudinal, or cohort studies that reported BLL and renal function tests among adult participants were retrieved from PubMed, Scopus, and ISI Web of Science. Read More

View Article and Full-Text PDF

Anti-Inflammatory and Anti-Hyperuricemic Effects of Chrysin on a High Fructose Corn Syrup-Induced Hyperuricemia Rat Model via the Amelioration of Urate Transporters and Inhibition of NLRP3 Inflammasome Signaling Pathway.

Antioxidants (Basel) 2021 Apr 6;10(4). Epub 2021 Apr 6.

Graduate Institute of Metabolism and Obesity Sciences, College of Nutrition, Taipei Medical University, Taipei 11031, Taiwan.

Hyperuricemia is the main cause of gout and involved in the occurrence of many other diseases such as hyperlipidemia and hypertension correlated with metabolic disorders. Chrysin is a flavonoid compound found naturally in honey, propolis, and mushrooms and has anti-inflammatory and antioxidant effects. However, its mechanism of action is not clear yet. Read More

View Article and Full-Text PDF

Uric acid participating in female reproductive disorders: a review.

Reprod Biol Endocrinol 2021 Apr 27;19(1):65. Epub 2021 Apr 27.

School of Medicine, Zhejiang University, No.866 Yuhantang Road, 310058, Hangzhou, People's Republic of China.

Uric acid (UA) is the end metabolic product of purine metabolism. Early on, UA was considered to be a metabolite with a certain antioxidant capacity. As research has progressed, other properties of UA have been explored, and its association with many diseases has been found. Read More

View Article and Full-Text PDF

The Role of Uric Acid in the Acute Myocardial Infarction: A Narrative Review.

Angiology 2021 Apr 27:33197211012546. Epub 2021 Apr 27.

Department of Medicine, Division of Nephrology, Koc University School of Medicine, Istanbul, Turkey.

Increased serum uric acid (SUA) levels have been associated with various pathologic processes such as increased oxidative stress, inflammation, and endothelial dysfunction. Thus, it is not surprising that increased SUA is associated with various adverse outcomes including cardiovascular (CV) diseases. Recent epidemiological evidence suggests that increased SUA may be related to acute myocardial infarction (AMI). Read More

View Article and Full-Text PDF

Correlation analysis between expression of histone deacetylase 6 and clinical parameters in IgA nephropathy patients.

Ren Fail 2021 Dec;43(1):684-697

Department of Nephrology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China.

Background: It has been demonstrated that histone deacetylase 6 (HDAC6) is involved in various kidney diseases in experimental study. However, correlation between HDAC6 and clinical parameters in IgA nephropathy (IgAN) patients is still unknown.

Methods: A total of 46 human kidney biopsy specimens with IgAN were selected as observation group, specimens of normal renal cortex tissue that was not affected by the tumor from patients with renal carcinoma ( = 7) served as control. Read More

View Article and Full-Text PDF
December 2021

Hyperuricemia and hypertriglyceridemia indicate tubular atrophy/interstitial fibrosis in patients with IgA nephropathy and membranous nephropathy.

Int Urol Nephrol 2021 Apr 24. Epub 2021 Apr 24.

Department of Nephrology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China.

Purpose: Hyperuricemia (HUA) and hypertriglyceridemia (HTG) were very common in chronic kidney disease (CKD) and associated with accelerated progression of CKD. This was a retrospective, cross-sectional study which aimed to explore the relationship between serum uric acid levels or triglyceride levels and tubular atrophy/interstitial fibrosis (proven by renal biopsy).

Methods: The present study enrolled 229 CKD individuals who included 127 biopsy-proven primary IgA nephrology (IgAN) patients and 102 biopsy-proven primary membranous nephropathy (MN) patients. Read More

View Article and Full-Text PDF

Cytotoxicity, Anti-diabetic, and hepato-protective potential of Ajuga bracteosa-conjugated silver nanoparticles in Balb/c mice.

Curr Pharm Biotechnol 2021 Apr 20. Epub 2021 Apr 20.

Department of Chemistry, University of Azad Jammu and Kashmir, Muzaffarabad, 13100, Pakistan.

Background: Ajuga bracteosa is a traditional herb used against various diseases.

Objective: Current research aimed to investigate the anti-diabetic and hepato-protective effect of green synthesized silver nanoparticles (ABAgNPs) using Ajuga bracteosa aqueous extract (ABaqu).

Methods: In vitro anti-diabetic and cytotoxic effects were carried out via α- glucosidase inhibition, brine shrimp lethality, and protein kinase inhibition assays. Read More

View Article and Full-Text PDF

Risk factors of contrast-induced nephropathy after percutaneous coronary intervention: a retrospective analysis.

J Int Med Res 2021 Apr;49(4):3000605211005972

Department of Cardiology, Yan'an University Affiliated Hospital, Yan'an, China.

Objective: Contrast-induced nephropathy (CIN) is a serious complication in patients with acute coronary syndrome (ACS) and percutaneous coronary intervention (PCI). This study aimed to analyze the potential risk factors for CIN in patients undergoing PCI.

Methods: Patients with ACS who underwent PCI treatment from January 2017 to January 2020 were selected. Read More

View Article and Full-Text PDF

Changes of serum advanced glycation end products (AGEs), matrix metalloprotein-2 (MMP-2), and urinary microalbuminuria (mALB) in diabetic nephropathy and their predictive value for heart failure.

Transl Androl Urol 2021 Mar;10(3):1279-1285

Department of Nephrology, the First Affiliated Hospital of Chongqing Medical University, Chongqing, China.

Background: Diabetic nephropathy is a common complication in diabetic patients, with a high rate of disability and mortality. This study aims to explore the changes in serum advanced glycation end products (AGEs), matrix metalloprotein-2 (MMP-2), and urinary microalbuminuria (mALB) in diabetic nephropathy and their predictive value for heart failure.

Methods: The 134 patients with diabetic nephropathy treated in our hospital from January 2014 to December 2017 were enrolled and divided into two groups resulting in 64 cases in an observation group with heart failure, and 70 cases without heart failure in a control group. Read More

View Article and Full-Text PDF

Hepatoprotective potential of kirenol on ethanol-induced liver toxicity in albino rats and acetaminophen-induced oxidative stress-mediated apoptosis in hepatic HepG2 cells.

J Biochem Mol Toxicol 2021 Apr 12:e22786. Epub 2021 Apr 12.

Department of General Surgery, The First Affiliated Hospital of Shandong First Medical University, Shandong Provincial Qianfoshan Hospital, Jinan, Shandong, China.

Liver diseases are a major health issue in both men and women and cause significant mortality worldwide. The hepatoprotective effects of kirenol were evaluated in acetaminophen (APAP)-induced toxicity in HepG2 cells and ethanol (EtOH)- induced hepatotoxicity in rats. The cytotoxicity of kirenol (IC , 25 µM/ml) and APAP (20 µg/ml) with sylimarin (IC , 15 µg/ml) was observed in HepG2 cells by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay. Read More

View Article and Full-Text PDF

The Pattern of Allopurinol Prescription Among Chronic Kidney Disease Patients in a Tertiary Care Centre: A Single-Centre Experience.

Int J Gen Med 2021 30;14:1141-1146. Epub 2021 Mar 30.

Medical College, Umm Alqura University (UQU), Makkah, 21441, Saudi Arabia.

Context: Hyperuricemia is prevalent in patients with chronic kidney disease (CKD). Although it is associated with CKD incidence and progression, treating asymptomatic hyperuricemia with uric acid-lowering agents is still debatable.

Aim Of Work: determine the rate of non-classical prescription of allopurinol in CKD patients. Read More

View Article and Full-Text PDF

Association between serum uric acid and major chronic diseases among centenarians in China: based on the CHCCS study.

BMC Geriatr 2021 04 7;21(1):231. Epub 2021 Apr 7.

Beijing Key Laboratory of Aging and Geriatrics, National Clinical Research Center for Geriatrics Diseases, State Key Laboratory of Kidney Diseases, Institute of Geriatrics, Second Medical Center of Chinese PLA General Hospital, Beijing, China.

Background: This study aims to analyze the distribution of serum uric acid (SUA) level based on more than 1000 centenarians and to explore the association with three common diseases including hypertension, diabetes and dyslipidemia.

Methods: All the 1002 centenarians from the CHCCS were included. Household survey was conducted. Read More

View Article and Full-Text PDF

MIF inhibitor ISO-1 alleviates severe acute pancreatitis-associated acute kidney injury by suppressing the NLRP3 inflammasome signaling pathway.

Int Immunopharmacol 2021 Apr 3;96:107555. Epub 2021 Apr 3.

Department of Emergency, The First Affiliated Hospital of Zhengzhou University, No 1 Eastern Jianshe Road, Zhengzhou 450052, Henan, China; Key Laboratory of Hepatobiliary and Pancreatic Surgery and Digestive Organ Transplantation of Henan Province, China; Henan Key Laboratory of Emergency and Trauma Research Medicine, China. Electronic address:

Background: Acute kidney injury (AKI) is an important complication of severe acute pancreatitis (SAP) with a poor prognosis. The methyl ester of (S,R)-3-(4-hydroxyphenyl)-4,5-dihydro-5-isoxazole acetic acid (ISO-1), an inhibitor of macrophage migration inhibitory factor (MIF), has protective effects against many diseases. Our previous study confirmed MIF inhibition alleviated SAP. Read More

View Article and Full-Text PDF

Is there any association between contrast-induced nephropathy and serum uric acid levels?

J Cardiovasc Thorac Res 2021 20;13(1):61-67. Epub 2021 Feb 20.

Cardiovascular Diseases Research Center, Department of Cardiology, Heshmat Hospital, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran.

During the recent years, several studies have investigated that hyperuricemia is associated with greater incidence of contrast induced nephropathy (CIN). Most of them are in acute conditions like primary percutaneous coronary interventions. This study aimed to assess the relationship between high serum uric acid and incidence of acute kidney injury in patients undergoing elective angiography and angioplasty. Read More

View Article and Full-Text PDF
February 2021

Correlation between serum carnosinase concentration and renal damage in diabetic nephropathy patients.

Amino Acids 2021 Apr 3. Epub 2021 Apr 3.

Department of Nephropathy, the First Affiliated Hospital of Anhui Medical University, Hefei, 230022, Anhui, People's Republic of China.

Diabetic nephropathy (DN) is one of the major complications of diabetes and contributes significantly towards end-stage renal disease. Previous studies have identified the gene encoding carnosinase (CN-1) as a predisposing factor for DN. Despite this fact, the relationship of the level of serum CN-1 and the progression of DN remains uninvestigated. Read More

View Article and Full-Text PDF

Influence of Short-Term Consumption of on Serum Biochemical Markers and the Changes of the Gut Microbiota: A Pilot Study.

Nutrients 2021 Mar 21;13(3). Epub 2021 Mar 21.

National Engineering Laboratory for Cereal Fermentation Technology, Jiangnan University, Wuxi 214122, China.

() is widely studied as a medicinal and edible fungus. Recent studies have shown that has protective effects for diseases, such as inflammatory bowel disease and cancer, which are related to gut microbiota. To investigate the benefits of intake on gut microbiota and blood indices in adulthood, we recruited 13 healthy adults to consume powder as a dietary supplement. Read More

View Article and Full-Text PDF

Quercetin-loaded F127 nanomicelles: Antioxidant activity and protection against renal injury induced by gentamicin in rats.

Life Sci 2021 Jul 27;276:119420. Epub 2021 Mar 27.

Department of Chemistry, International Hellenic University, Kavala, Greece. Electronic address:

Quercetin (Q) is formulated into oil-in-water F127 microemulsions to improve its bioavailability. The size of the Q-loaded microemulsions system was about 8 nm by dynamic light scattering analysis. To compare antioxidant activity of bulk solution and microemulsion of Q, free radical scavenging activity was evaluated against 2,2-diphenyl-1-picrylhydrazyl (DPPH). Read More

View Article and Full-Text PDF

Different clinical impact of hyperuricemia according to etiologies of chronic kidney disease: Gonryo Study.

PLoS One 2021 25;16(3):e0249240. Epub 2021 Mar 25.

Division of Nephrology, Hypertension and Endocrinology, Tohoku University, Sendai, Japan.

Background: Hyperuricemia is highly prevalent in chronic kidney disease (CKD) patients, but the evidence for a relationship between uric acid (UA) and clinical outcomes in CKD patients is limited and inconsistent. We hypothesized that UA has a different impact on clinical outcomes according to the underlying disease causing CKD.

Methods: This study prospectively investigated the associations between UA and renal and non-renal outcomes according to the underlying disease causing CKD in 2,797 Japanese patients under the care of nephrologists. Read More

View Article and Full-Text PDF

Thinking Outside the Box: Novel Kidney Protective Strategies in Kidney Transplantation.

Clin J Am Soc Nephrol 2021 Mar 23. Epub 2021 Mar 23.

Division of Nephrology, Department of Medicine, Ottawa Hospital and Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.

Despite the reduction in the incidence of acute rejection, a major risk factor for graft loss, there has been only modest improvement in long-term graft survival. Most cases of kidney graft loss have an identifiable cause that is not idiopathic fibrosis/atrophy or calcineurin inhibitor nephrotoxicity. Distinct immunologic and nonimmunologic factors conspire to lead to a common pathway of allograft fibrosis. Read More

View Article and Full-Text PDF

Association of uric acid with kidney function and albuminuria: the Uric Acid Right for heArt Health (URRAH) Project.

J Nephrol 2021 Mar 23. Epub 2021 Mar 23.

Department of Medicine, University of Padua, Padua, Italy.

Background: Hyperuricemia is commonly observed in patients with chronic kidney disease (CKD). However, a better understanding of the relationship among uric acid (UA) values, glomerular filtration rate (GFR) and albuminuria may shed light on the mechanisms underlying the excess of cardiovascular mortality associated with both chronic kidney disease and hyperuricemia and lead to better risk stratification. Our main goal was to study the relationships between serum uric acid and kidney disease measures (namely estimated GFR [eGFR] and albuminuria) in a large cohort of individuals at cardiovascular risk from the URic acid Right for heArt Health (URRAH) Project database. Read More

View Article and Full-Text PDF